Brief: Dr Lalchandani Labs - Board Meet For Rights Issue Terms Deferred Due To Non-Receipt Of BSE Approval
22/12/2025 12:18
Dec 22 (Reuters) - Dr Lalchandani Labs Ltd DRLA.BO: BOARD MEET FOR RIGHTS ISSUE TERMS DEFERRED DUE TO NON-RECEIPT OF BSE APPROVAL Source text: ID:nBSE7LCpW9 Further company coverage: DRLA.BO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr Lalchandani Labs
See all newsBrief: Dr Lalchandani Labs - Board Meet For Rights Issue Terms Deferred Due To Non-Receipt Of BSE Approval
Brief: Dr Lalchandani Labs Approves Rights Issue Up To 43.3 Million Rupees
Brief: Dr Lalchandani Labs Raising Funds Via Rights Issue Up To 43.3 Million Rupees
Brief: Dr Lalchandani To Consider Fund Raising on Dec 9 Board Meeting
Brief: Dr Lalchandani Labs Announces Another Grant Of Empanelment Of Delhi Municipal Corp